VP24 of Marburg virus influences formation of infectious particles

Journal of Virology

Volumn 79, Issue 21, 2005, Pages 13421-13433

  Bamberg, Sandra ^a   Kolesnikova, Larissa ^a   Möller, Peggy ^a   Klenk, Hans Dieter ^a   Becker, Stephan ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX PROTEIN; PROTEIN VP24; PROTEIN VP30; PROTEIN VP35; SMALL INTERFERING RNA; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; HUMAN; HUMAN CELL; MARBURG VIRUS; MEMBRANE BINDING; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TRANSCRIPTION REGULATION; VIRUS EXPRESSION; VIRUS GENOME; VIRUS NUCLEOCAPSID; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; CELL LINE; CELL MEMBRANE; HUMANS; MARBURGVIRUS; MICROSCOPY, FLUORESCENCE; MICROSCOPY, IMMUNOELECTRON; NUCLEOCAPSID; PROVIRUSES; VIRAL PROTEINS; VIRION; VIRUS ASSEMBLY;

LAKE VICTORIA MARBURGVIRUS; RNA VIRUSES;

EID: 27144503018     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.21.13421-13433.2005     Document Type: Article

References (31)

1. Becker, S., C. Rinne, U. Hofsass, H. D. Klenk, and E. Mühlberger. 1998. Interactions of Marburg virus nucleocapsid proteins. Virology 249:405-417.
2. Bergmann, J. E., and P. J. Fusco. 1988. The M protein of vesicular stomatitis virus associates specifically with the basolateral membranes of polarized epithelial cells independently of the G protein. J. Cell Biol. 107:1707-1715.
3. Bitko, V., and S. Bank. 2001. Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses. BMC Microbiol. 1:34.
4. Bordier, C. 1981. Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 256:1604-1607.
5. Cheusova, T. B., S. Becker, E. Muehlberger, and E. I. Ryabchikova. 2002. Submicroscopic characteristics of Marburg virus and its mini genome analog replication in cell cultures. Mol. Gen. Mikrobiol. Virusol. 2:27-30. (In Russian.)
6. Elbashir, S. M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498.
7. Feldmann, H., and M. P. Kiley. 1999. Classification, structure, and replication of filoviruses. Curr. Top. Microbiol. Immunol. 235:1-21.
8. Feldmann, H., E. Muhlberger, A. Randolf, C. Will, M. P. Kiley, A. Sanchez, and H. D. Klenk. 1992. Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res. 24:1-19.
9. Feldmann, H., C. Will, M. Schikore, W. Slenczka, and H. D. Klenk. 1991. Glycosylation and oligomerization of the spike protein of Marburg virus. Virology 182:353-356.
10. Feigner, J. H., R. Kumar, C. N. Sridhar, C. J. Wheeler, Y, J. Tsai, R. Border, P. Ramsey, M. Martin, and P. L. Felgner. 1994. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 269:2550-2561.
11. Fowler, T., S. Bamberg, P. Möller, H.-D. Klenk, T. F. Meyer, S. Becker, and T. Rudel. 2005. Inhibition of Marburg virus protein expression and viral release by RNA interference. J. Gen. Virol. 86:1181-1188.
12. Fuerst, T. R., E. G. Niles, F. W. Studier, and B. Moss. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8126.
13. Funke, C., S. Becker, H. Dartsch, H. D. Klenk, and E. Muhlberger. 1995. Acylation of the Marburg virus glycoprotein. Virology 208:289-297.
14. Ge, Q., M. T. McManus, T. Nguyen, C. H. Shen, P. A. Sharp, H. N. Eisen, and J. Chen. 2003. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc. Natl. Acad. Sci. USA 100:2718-2723.
15. Han, Z., H. Boshra, J. O. Sunyer, S. H. Zwiers, J. Paragas, and R. N. Harty. 2003. Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding. J. Virol. 77:1793-1800.
16. Huang, Y., L. Xu, Y. Sun, and G. J. Nabel. 2002. The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein. Mol. Cell 10:307-316.
17. Isas, J. M., J. P. Cartailler, Y. Sokolov, D. R. Patel, R. Langen, H. Luecke, J. E. Hall, and H. T. Haigler. 2000. Annexins V and XII insert into bilayers at mildly acidic pH and form ion channels. Biochemistry 39:3015-3022.
18. Kolesnikova, L., S. Bamberg, B. Berghofer, and S. Becker. 2004. The matrix protein of Marburg virus is transported to the plasma membrane along cellular membranes: exploiting the retrograde late endosomal pathway. J. Virol. 78:2382-2393.
19. Kolesnikova, L., B. Berghöfer, S. Bamberg, and S. Becker. 2004. Multivesicular bodies as a platform for the formation of Marburg virus envelope. J. Virol. 78:12277-12287.
20. Kolesnikova, L., H. Bugany, H. D. Klenk, and S. Becker. 2002. VP40, the matrix protein of Marburg virus, is associated with membranes of the late endosomal compartment. J. Virol. 76:1825-1838.
21. Kolesnikova, L., E. Mühlberger, E. Ryabchikova, and S. Becker. 2000. Ultrastructural organization of recombinant Marburg virus nucleoprotein: comparison with Marburg virus inclusions. J. Virol. 74:3899-3904.
22. Licata, J. M., R. F. Johnson, Z. Han, and R. N. Harty. 2004. Contribution of Ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles. J. Virol. 78:7344-7351.
23. Modrof, J., C. Moritz, L. Kolesnikova, T. Konakova, B. Hartlieb, A. Randolf, E. Mühlberger, and S. Becker. 2001. Phosphorylation of Marburg virus VP30 at serines 40 and 42 is critical for its interaction with NP inclusions. Virology 287:171-182.
24. Mühlberger, E., B. Lotfering, H. D. Klenk, and S. Becker. 1998. Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes. J. Virol. 72:8756-8764.
25. Saksela, K. 2003. Human viruses under attack by small inhibitory RNA. Trends Microbiol. 11:345-347.
26. Sänger, C., E. Mühlberger, E. Ryabchikova, L. Kolesnikova, H. D. Klenk, and S. Becker. 2001. Sorting of Marburg virus surface protein and virus release take place at opposite surfaces of infected polarized epithelial cells. J. Virol. 75:1274-1283.
27. Sutter, G., M. Ohlmann, and V. Erfle. 1995. Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase. FEBS Lett. 371:9-12.
28. Swenson, D. L., K. L. Warfield, K. Kuehl, T. Larsen, M. C. Hevey, A. Schmaljohn, S. Bavari, and M. J. Aman. 2004. Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein. FEMS Immunol. Med. Microbiol. 40:27-31.
29. Traggiai, E., S. Becker, K. Subbarao, L. Kolesnikova, Y. Uematsu, M. R. Gismondo, B. R. Murphy, R. Rappuoli, and A. Lanzavecchia. 2004. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med. 10:871-875.
30. Volchkov, V. E., A. A. Chepurnov, V. A. Volchkova, V. A. Ternovoj, and H. D. Klenk. 2000. Molecular characterization of guinea pig-adapted variants of Ebola virus. Virology 277:147-155.
31. Watanabe, S., T. Watanabe, T. Noda, A. Takada, H. Feldmann, L. D. Jasenosky, and Y. Kawaoka. 2004. Production of novel Ebola virus-like particles from cDNAs: an alternative to Ebola virus generation by reverse genetics. J. Virol. 78:999-1005.